Cullinan Therapeutics CGEM Growth Metrics (2021-2026)

NASDAQ CGEM
$22.10 -0.06 (-0.27%)
As of: Sep 4, 2026 · 3:14 PM EDT
Reported Financials

Cullinan Therapeutics Quarterly Growth Metrics

Periods 21 quarters
Latest Jun 2026

Cullinan Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Dividend Coverage Ratio (QoQ)Div. Cover (QoQ)
-457.59%
FCF Payout Ratio (QoQ)FCF Cover (QoQ)
81.61%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-347.003,143.002,949.003,370.003,059.00-4713.00-4671.00-5023.00-4065.00198.00903.00545.00-93.00-1204.00-2130.00-2083.00-2213.00-1579.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-1353.00-1373.00-818.00-1108.00-1100.00-5719.00-5897.00-6561.00-6372.00-2585.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-3660.00-4156.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-185.00-156.00-354.003,838.00-379.00264.00-665.00-3934.00-336.00-88.00293.00329.00370.00-446.00-346.00-782.00-557.00-399.00-476.00-147.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-844.004,346.003,715.004,120.004,666.00-6409.00-5998.00-6695.00-6089.00-129.00762.00898.00207.00-1105.00-2229.00-2395.00-2511.00-1975.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-2267.00-2192.00-1522.00-1677.00-1216.00-7643.00-7466.00-8192.00-8392.00-3209.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-4571.00-5272.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-193.00-175.00-860.005,575.00-824.00229.00-315.00-5500.00-413.00-467.00291.00460.00477.00-331.00-399.00-853.00-646.00-497.00-515.00-317.00